コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 inogen to fibrin and subsequent formation of fibrin degradation products.
2 ng time or platelet count but exhibited less fibrin degradation products (1/6 animals) than did contr
4 n degrades the crosslinked fibrin to release fibrin degradation products and expose the D-dimer antig
6 emostatic components (fibrinogen, platelets, fibrin degradation products) and inflammatory mediators
7 on to a 3-BRS comprising C-reactive protein, fibrin degradation product, and heat shock protein-70 im
8 stment for risk factors, C-reactive protein, fibrin degradation product, and heat shock protein-70.
10 ing levels of biomarkers C-reactive protein, fibrin degradation products, and heat shock protein-70 r
11 ular coagulation (activated prothombin time, fibrin degradation products, and one-step prothombin tim
12 Leukocyte changes, fibrinogen consumption, fibrin degradation products, and vital signs were simila
13 lobal blood coagulation markers (fibrinogen, fibrin-degradation products, APTT), and preserved the en
14 ing decreases in fibrinogen and increases in fibrin degradation products at 3 x 10(12)vp, precluded a
15 Previous studies have shown that fibrin and fibrin degradation products can have biologic effects on
16 , thrombin-antithrombin complex, crosslinked fibrin degradation product D-dimer, and thrombin-activat
19 artial thromboplastin time (PTT), fibrinogen/fibrin degradation products (FDP), and fibrinogen were u
20 s-high-sensitivity C-reactive protein (CRP), fibrin degradation products (FDP), and heat shock protei
22 proteolysis of cross-linked fibrin generates fibrin degradation products (FDPs) with multiple biologi
25 ibrinogen concentrations and the increase in fibrin degradation products observed in the control grou
26 rediction rule were performed, and levels of fibrin degradation products (plasma D-dimers) were asses
29 ies suggest that histones and DNA bind large fibrin degradation products with 191 and 136 nM dissocia
30 e of substantial amounts of fibrin(ogen) and fibrin degradation products within intimal lesions, the
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。